Di Li, Artursson Per, Avdeef Alex, Benet Leslie Z, Houston J Brian, Kansy Manfred, Kerns Edward H, Lennernäs Hans, Smith Dennis A, Sugano Kiyohiko
Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, CT 06340, USA.
Department of Pharmacy, Uppsala University, 752 36, Uppsala, Sweden.
ChemMedChem. 2020 Oct 19;15(20):1862-1874. doi: 10.1002/cmdc.202000419. Epub 2020 Sep 10.
Passive permeability is a key property in drug disposition and delivery. It is critical for gastrointestinal absorption, brain penetration, renal reabsorption, defining clearance mechanisms and drug-drug interactions. Passive diffusion rate is translatable across tissues and animal species, while the extent of absorption is dependent on drug properties, as well as in vivo physiology/pathophysiology. Design principles have been developed to guide medicinal chemistry to enhance absorption, which combine the balance of aqueous solubility, permeability and the sometimes unfavorable compound characteristic demanded by the target. Permeability assays have been implemented that enable rapid development of structure-permeability relationships for absorption improvement. Future advances in assay development to reduce nonspecific binding and improve mass balance will enable more accurately measurement of passive permeability. Design principles that integrate potency, selectivity, passive permeability and other ADMET properties facilitate rapid advancement of successful drug candidates to patients.
被动通透性是药物处置和递送中的关键性质。它对于胃肠道吸收、脑渗透、肾脏重吸收、确定清除机制以及药物-药物相互作用至关重要。被动扩散速率在不同组织和动物物种之间具有可转换性,而吸收程度则取决于药物性质以及体内生理学/病理生理学。已经制定了设计原则来指导药物化学以增强吸收,这些原则结合了水溶性、通透性的平衡以及靶点所要求的有时不利的化合物特性。已经实施了通透性测定法,可实现结构-通透性关系的快速发展以改善吸收。未来在测定法开发方面减少非特异性结合并改善质量平衡的进展将能够更准确地测量被动通透性。整合效力、选择性、被动通透性和其他ADMET性质的设计原则有助于成功的候选药物迅速进入患者体内。